A rapid experimental genetic test can help guide the hands of surgeons as they delicately remove tumors from patients with brain cancer, new research suggests.

The removal of a malignant brain tumor or glioma can extend a patient's life by many years depending on the type of glioma. However, it can also mark the start of another difficult health journey.

Geddy has lived a big life for a little dog. As a puppy, the tiny terrier mix was abandoned in Mississippi during a high-speed car chase. Rescued by law enforcement, she found a loving home in ...

For female patients with glioma, pregnancy after receiving a diagnosis of glioma is associated with worse progression-free ...

New findings from researchers at the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute could help make immunotherapies for brain cancer more effective. The team analyzed almost ...

In an earlier study, patients with biomarker-positive high-grade glioma lived longer after treatment with DB107 than biomarker-negative patients.

Malignant gliomas and medulloblastomas — the most common brain tumours affecting adults and children, respectively — remain responsible for a disproportionate level of morbidity and mortality ...

Anova Enterprises, Inc. (Anova), a technology-enabled CRO dedicated to accelerating promising treatments, has announced enrollment of the first two pa ...